A plasmid containing the Escherichia coli chloramphenicol acetyltransferase (CAT) gene under the control of a mammalian cAMP-regulated promoter was entrapped in H-2Kk antibody-coated liposomes composed of dioleoyl phosphatidylethanolamine, cholesterol, and oleic acid (pHsensitive immunoliposomes). The entrapped or free DNA was injected intraperitoneally into immunodeficient (nude) BALB/c mice bearing ascites tumor generated by H-2K"-positive RDM-4 lymphoma cells. About 20% of the injected immunoliposomes were taken up by the target RDM-4 cells. Uptake was much less when liposomes without antibody were used. The presence of the targeting antibody on liposomes also significantly decreased the nonspecific uptake of liposomes by the spleen. Significant CAT enzyme activity was detected in RDM-4 cells from mice treated with DNA entrapped in the pH-sensitive immunoliposomes. Furthermore, CAT expression in RDM-4 cells was under the control of cAMP, as only the cells from mice injected with 8-bromo-cAMP and 3-isobutyl-1-methylxanthine showed CAT activity. CAT activity in liver and spleen was much lower (by factors of 12 and 5, respectively) than in the RDM-4 cells, and the activities in these reticuloendothelial organs were not regulated by cAMP. CAT activity in RDM-4 cells from mice injected with DNA entrapped in pH-insensitive immunoliposomes (containing phosphatidylcholine in place of phosphatidylethanolamine) was approximately one-fourth that in RDM-4 cells from mice injected with pH-sensitive immunoliposomes, indicating the superior delivery efficiency of the pH-sensitive liposomes. These results are discussed in terms of the DNA-carrier potential of immunoliposomes in therapy of cancer and genetic diseases.
RDM-4 cells from mice treated with DNA entrapped in the pH-sensitive immunoliposomes. Furthermore, CAT expression in RDM-4 cells was under the control of cAMP, as only the cells from mice injected with 8-bromo-cAMP and 3-isobutyl-1-methylxanthine showed CAT activity. CAT activity in liver and spleen was much lower (by factors of 12 and 5, respectively) than in the RDM-4 cells, and the activities in these reticuloendothelial organs were not regulated by cAMP. CAT activity in RDM-4 cells from mice injected with DNA entrapped in pH-insensitive immunoliposomes (containing phosphatidylcholine in place of phosphatidylethanolamine) was approximately one-fourth that in RDM-4 cells from mice injected with pH-sensitive immunoliposomes, indicating the superior delivery efficiency of the pH-sensitive liposomes. These results are discussed in terms of the DNA-carrier potential of immunoliposomes in therapy of cancer and genetic diseases.
Correction of genetic disorders by gene therapy is one of the developing areas in medicine (1) . The exogenous normal gene that is introduced may replace or coexist with the defective gene and produce normal gene product. Successful therapy of a genetic disorder requires knowledge of the structure, function, and regulation of the gene to be introduced into the deficient cell, as well as an efficient and specific means of delivering the gene to the target cell. Despite its great potential in medicine and biotechnology, gene therapy has not yet been used widely, mainly due to the poor efficiency of DNA delivery. Current methods of delivery of new genetic information into cells in vitro (for review, see ref. 1) include cell fusion, chromosome-mediated insertion, microcell-mediated gene transfer, liposome DNA carriers, spheroplast fusion, DNA-mediated gene transfer, microinjection, infection with recombinant RNA viruses, and infection with recombinant DNA viruses. However, most of these techniques are not applicable for use in animals or humans because of low efficiency, instability of introduced genes, introduction of extraneous or undesirable genetic information, and lack of target specificity.
To improve the efficiency of delivery of biologically functional molecules, pH-sensitive liposomes have been developed in several laboratories including ours (2, 3) . These liposomes release their contents into the cytoplasm of target cells after they fuse with the endosomal membrane (4) . In previous studies, we used a water-soluble fluorescent dye, calcein, as a convenient marker for observing cytoplasmic delivery (5) and used the herpes simplex virus thymidine kinase gene as a selectable marker for gene transfer (6) . The results indicated that the liposome contents were released into the cytoplasm and that the transferred DNA can be expressed with high efficiency in target cells.
To increase specific binding of liposomes to target cells, acylated monoclonal antibodies were incorporated into the lipid bilayer ofthe liposome (7) . The present study is tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (8) by replacing the promoter region with a 621-base-pair upstream sequence of the rat phosphoenolpyruvate carboxykinase gene, which contains a cAMP regulatory sequence (9) . Details of the plasmid construction will be published elsewhere. Plasmid DNA was prepared and purified by standard techniques (10) .
Liposome Preparation. Methods used for the preparation of large unilamellar immunoliposomes were based on the procedure of Philippot et al. (11) (12) . The lipid suspension was sonicated with a bath sonicator (Laboratory Supplies, Hicksville, NY) and the pH was adjusted to 8. Palmitoylated anti-H2-Kk (1/25th of total lipid by weight), octyl glucoside (100 ,umol), and DNA (150 Ag) were added, and the mixture (final volume, 0.34 ml) was dialyzed at 4°C against 100 ml of 10 mM Tris.HCl/1 mM EDTA/150 mM NaCl (pH 8) and 1 g of washed SM-2 beads (13) overnight without stirring the dialysis buffer. Stirring was started the next morning. After 24 hr in dialysis, the buffer and beads were replaced with fresh ones and the dialysis was continued for an additional 24 hr. The liposomes were extruded through a polycarbonate filter of 0.2-,um pore diameter (Nuclepore) to obtain liposomes of uniform size distribution. Subsequently, the liposomes were separated from free DNA by gel filtration using a column of autoclaved Sepharose CL-2B (Pharmacia).
Inoculation of Mice. RDM-4 lymphoma cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum and 0.01% sodium pyruvate. RDM-4 cells (107) in 0.5 ml of phosphate-buffered isotonic saline (pH 7.4) were inoculated intraperitoneally (i.p.) in 6-week-old nude mice. After 7 days, the mice were injected i.p. with liposomeentrapped or free DNA at a dose of 20 ,g of DNA (-8.9 ,umol of lipid) per mouse. Twenty-four hours later, (1 mg/100 g of body weight) and iBuMeXan (0.5 mg/100 g) were injected i.p. After 5 hr, ascites fluid was harvested from the peritoneal cavity by five 2-ml injections of phosphate-buffered saline. The ascites fluid, which contained RDM-4 cells and macrophages, was incubated in a glass Petri dish for 6 hr.
The nonadherent RDM-4 cells were harvested from the supernatant, and adherent macrophages were harvested from the glass with a cell scraper. After centrifugation, cell pellets were resuspended in 0.25 mM Tris HCl (pH 7.4) for CAT activity assay. The blood, hearts, spleens, lungs, stomachs, kidneys, and livers of the mice were also collected and homogenized. An aliquot of each homogenized organ was dissolved in Protosol (New England Nuclear) for measurement of 3H by liquid scintillation counting. After centrifugation, the organ extracts were assayed for CAT activity. Two mice per group were used. Variations of data between experiments were less than 15%.
CAT Assay. CAT activity was determined by a modification of the method of Gorman et al. (14) . Ascites Immunoliposomes that had not been filter-extruded, and thus were larger in size, seemed more efficient than those that had been extruded. In all cases, gene expression in the adherent cells (macrophages) was fairly low.
CAT Activity in the Organs of Nude Mice. To examine whether the foreign gene was expressed in the organs of nude mice, CAT activity in the organ extracts was also assayed. Extracts from kidney, heart, and lung showed no detectable CAT activity with any type of liposome treatment (Table 2) . However, spleens and livers of the tumor-bearing mice treated with pH-sensitive immunoliposomes, but not with pH-insensitive immunoliposomes or free DNA, showed low levels of CAT activity. Extracts from stomachs of the treated mice showed variable amounts of CAT activity. A separate examination of untreated normal nude mouse showed similar CAT activity in the stomach. Since the food residues in the stomach were not removed before the extract was prepared, the CAT activity in the stomach extract was probably due to the microorganisms in the food residues.
DISCUSSION
This paper provides evidence that pH-sensitive immunoliposomes can mediate target-specific DNA delivery in an animal model. In the current study, the mice bearing no tumor cells but treated with immunoliposomes and the tumor-bearing mice treated with antibody-free liposomes showed a high degree of accumulation of liposome in the spleen, whereas the tumor-bearing mice treated with immunoliposomes had a much lower liposome accumulation in the spleen. Although the accumulation in the RDM-4 cells was only modestly (about 2-fold) increased in the latter case, it is clear that the biodistribution of the immunoliposomes is significantly different from that of the antibody-free liposomes. Nonspecific uptake by spleen cells is likely due to the reticuloendothelial cells (macrophages), which are also abundant in liver. However, accumulation in liver was fairly low. This observation may be unique to the nude mice since i.p. injected liposomes normally accumulate in the liver of mouse (16) . Further studies are required to clarify this point. Although the target RDM-4 cells were not the only cells in the mouse to which pH-sensitive immunoliposomes bound, the RDM-4 cells were the only ones that expressed significant CAT activity in response to 8-Br-cAMP plus iBuMeXan. The adherent cells (macrophages) isolated from the same peritoneal cavity did not express significant amounts of enzyme activity despite the fact that they accumulated some liposomes. Furthermore, the spleen cells in the non-tumorbearing mice, which took up a large amount of the pHsensitive immunoliposomes, showed only a very low level of gene expression. There are several possible explanations for this observation. It is possible that the liposomes were unstable in the mouse peritoneal cavity, resulting in separation of DNA from liposomes. The liposome remnants might have then entered the circulation via the thoracic duct and been taken up by the macrophages in the spleen. Other possibilities are that DNA was degraded in the macrophages or that the intact DNA was delivered but could not be efficiently expressed in macrophages because of the lack of cAMP regulatory factor(s) . Wynshaw-Boris et al. (9) (5, 18) . The same experiment also showed that larger, unextruded liposomes were more effective delivery vehicles than the smaller, extruded ones (Table 3 ). This result is not consistent with our previous results of in vitro experiments in which extruded liposomes were more efficient in delivering the herpes simplex virus thymidine kinase gene to mouse Ltk-cells (6) (20) also showed that liposomes bearing galactosyl groups were targeted to hepatocytes. However, our work differs from their work in several important ways. Our previous work (6) and the work described here indicate that pHsensitive immunoliposomes give more efficient cytoplasmic delivery than pH-insensitive immunoliposomes. The current study utilized an antibody instead of galactosyl groups to direct the liposomes to the target cells. Although the uptake of liposomes by reticuloendothelial cell-rich tissues such as spleen could not be avoided, our immunoliposome system exhibited target specificity in gene delivery.
The implications of our results for cancer therapy cannot be overlooked. DNA coding for cytotoxins such as diphtheria toxin (21) could be delivered to the target tumor cells. This type of chemotherapy is potentially superior to the immunoliposome-mediated delivery of conventional cytotoxic drugs such as methotrexate in several ways. First, the action of a gene should be much more potent than the action of a drug, due to a large degree of amplification through transcription and translation. Second, if DNA leaks out of the liposomes it should not be toxic because of rapid digestion by extracellular nuclease, whereas free cytotoxic drugs are toxic to normal tissues. Third, our results indicate that although the host organs took up liposomes, they did not significantly express the exogenous gene. This added level of specificity in cancer therapy may be very important, because by selecting appropriate control mechanisms, the delivered toxic gene may be expressed only in the tumor cells.
Our work also has implications for gene therapy. Two potential advantages of the antibody-coated liposomes in delivering DNA are their high transfer efficiency and safety. Successful human gene therapy will require efficient gene transfer and proper expression of the delivered gene in appropriate target cells (22) . Retroviral vectors have been used as successful gene carriers (for review, see ref. 23 ). In many cases, the transferred genes were expressed in several hematopoietic cell types in vitro and in murine bone marrow stem cells. Although the retrovirus system has a much higher transformation efficiency than the conventional liposomes do, the viral oncogene and the random insertion of the retroviral genome into the host genome are undesirable side effects. The pH-sensitive immunoliposomes may be a good compromise in this regard. Furthermore, the fact that expression of the liposome-delivered gene can be properly controlled by an external signal, such as cAMP in the present study, is also an important advantage in human gene therapy.
